###begin article-title 0
Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis
###end article-title 0
###begin p 1
###xml 35 53 35 53 <email xmlns:xlink="http://www.w3.org/1999/xlink">dematter@mskcc.org</email>
CORRESPONDENCE Ronald P. DeMatteo: dematter@mskcc.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 599 602 599 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 754 757 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 968 971 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1295 1300 <span type="species:ncbi:9606">human</span>
The high rate of mortality in patients with sepsis results from an inappropriately amplified systemic inflammatory response to infection. Toll-like receptors (TLRs) are important for the activation of innate immunity against microbial pathogens. We demonstrate a critical role of TLR9 in the dysregulated immune response and death associated with sepsis. Compared with wild-type (WT) mice, TLR9-/- mice exhibited lower serum inflammatory cytokine levels, higher bacterial clearance, and greater survival after experimental peritonitis induced by cecal ligation and puncture (CLP). Protection of TLR9-/- mice after CLP was associated with a greater number of peritoneal dendritic cells (DCs) and granulocytes than in WT controls. Adoptive transfer of TLR9-/- DCs was sufficient to protect WT mice from CLP and increased the influx of peritoneal granulocytes. Subsequent experiments with a depleting antibody revealed that granulocytes were required for survival in TLR9-/- mice. Remarkably, a single injection of an inhibitory CpG sequence that blocks TLR9 protected WT mice, even when administered as late as 12 h after CLP. Our findings demonstrate that the detrimental immune response to bacterial sepsis occurs via TLR9 stimulation. TLR9 blockade is a potential strategy for the treatment of human sepsis.
###end p 3
###begin p 4
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 619 620 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 758 759 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 325 330 <span type="species:ncbi:9606">human</span>
Sepsis remains the leading cause of death in critically ill patients, with mortality rates ranging between 30 and 70% (1). The syndrome of sepsis develops when the initially appropriate host response to infection becomes excessive, resulting in widespread inflammation and multiorgan failure (2). Several strategies to treat human sepsis have targeted proinflammatory mediators. Unfortunately, most of these therapies have not proven to be efficacious in large multicenter clinical trials (3). Blockade of TNF, IL-1beta, bradykinin, platelet-activating factor, elastase, nitric oxide, and LPS has not affected outcome (4). In addition, it was recently demonstrated that corticosteroid therapy for septic shock failed to alter survival in a randomized trial (5). Consequently, the current treatment of sepsis is largely supportive, and definitive therapies have remained elusive.
###end p 4
###begin p 5
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1040 1041 1040 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1156 1157 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1174 1177 1174 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1442 1443 1442 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1178 1182 <span type="species:ncbi:10090">mice</span>
###xml 1299 1304 <span type="species:ncbi:10090">mouse</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1436 1440 <span type="species:ncbi:10090">mice</span>
Septic peritonitis has a particularly high mortality and is characterized by a massive infiltration of neutrophils into the peritoneum, where they act as a first line of defense against microbial pathogens. When innate defenses become overwhelmed, bacteria escape the peritoneum and disseminate throughout the host, inducing an exaggerated inflammatory response (2). Immune recognition of bacteria occurs via pattern-recognition receptors that detect conserved microbial components or products (6). The best-characterized pattern-recognition receptors are the Toll-like receptors (TLRs). There are at least 10 TLRs in mammals. TLR4 functions as the signal-transducing receptor for LPS, and TLR2 detects a broad range of Gram-positive bacterial products, including lipotechoic acid and peptidoglycan. The ligands for TLR9 are unmethylated CpG motifs present in bacterial DNA (6). The importance of TLRs in the pathogenesis of sepsis has been demonstrated in mice deficient in the signaling protein myeloid differentiation factor 88 (MyD88) (7). MyD88 has been identified as a central adaptor protein for the signal transduction of all TLRs except for TLR3 (8). Although MyD88-/- mice have attenuated responses to polymicrobial infection, the contribution of individual TLRs seems less critical. In a mouse model of septic peritonitis, it was shown that mice with single or combined deficiency in TLR2 and TLR4 had similar survival as WT mice (7). These surprising findings raised the possibility that individual TLRs are dispensable for the progression of bacterial sepsis and instead support an alternative hypothesis that stimulation of multiple TLRs is needed for an overwhelming inflammatory response. In this report, however, we show that eliminating TLR9 stimulation is sufficient to avert the unrestrained immune response in polymicrobial sepsis.
###end p 5
###begin title 6
RESULTS AND DISCUSSION
###end title 6
###begin title 7
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
TLR9-/- mice are resistant to polymicrobial sepsis
###end title 7
###begin p 8
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 173 176 173 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 234 242 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 351 359 351 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 384 392 384 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 459 467 459 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 946 949 946 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1008 1016 1008 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1057 1060 1057 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1249 1252 1249 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1296 1304 1296 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1376 1379 1376 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1386 1394 1386 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 1425 1428 1425 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1550 1558 1550 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1061 1065 <span type="species:ncbi:10090">mice</span>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
###xml 1544 1548 <span type="species:ncbi:10090">mice</span>
To determine the relative importance of TLR9 stimulation in polymicrobial sepsis, we performed cecal ligation and puncture (CLP) in TLR9-/- mice. Strikingly, nearly all TLR9-/- mice survived, whereas WT mice died at a median of 24 h (Fig. 1 A). The increased survival of TLR9-/- mice was associated with enhanced clearance of bacteria from the blood (Fig. 1 B) and peritoneal cavity (Fig. 1 C), as well as a dramatic decrease in serum inflammatory cytokines (Fig. 1 D). The reduction in cytokine levels was most evident at 12 h and ranged between 15- and 300-fold, depending on the particular cytokine. To understand the basis of protection, we analyzed the cellular composition of the spleen and peritoneum. Compared with animals undergoing sham laparotomy, WT mice that underwent CLP had fewer splenocytes, which was consistent with previous data demonstrating apoptosis of splenic lymphocytes during sepsis (9). In contrast, we found that TLR9-/- mice had a greater number of total splenocytes after CLP (Fig. 2 A). The absence of lymphodepletion in TLR9-/- mice likely contributed to their protection because inhibiting apoptosis improves survival in sepsis (10). In the peritoneum, the number of lymphocytes increased markedly after CLP in TLR9-/- animals and to a lesser extent in WT mice (Fig. 2 B). Consistent with our findings of reduced serum cytokine levels in TLR9-/- mice (Fig. 1 D), the peritoneal cells of TLR9-/- mice isolated 12 h after CLP and cultured without restimulation made fewer cytokines than peritoneal cells from WT mice (Fig. 2 C).
###end p 8
###begin p 9
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR9<sup>&#8722;/&#8722;</sup> mice have less inflammation and increased survival after CLP.</bold>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
TLR9-/- mice have less inflammation and increased survival after CLP. (A) The survival rates of WT B6 and TLR9-/- mice were monitored for 6 d after CLP (15 mice per group, with data pooled from three experiments, each of which had similar statistical significance). Dilutions of blood (B) or peritoneal lavage fluid (C) obtained from TLR9-/- or WT mice 12 h after CLP were cultured on BHI agar plates, and the number of bacterial colonies was counted (five mice per group). The colony count indicated is of 1 ml of blood and 1 ml of peritoneal fluid. (D) Serum cytokine levels were determined 6 and 12 h after CLP by using a cytometric bead array (five mice per group). Data shown are means of values +/- SEM obtained from individual mice and are representative of at least two independent experiments. *, P < 0.05.
###end p 9
###begin p 10
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR9<sup>&#8722;/&#8722;</sup> mice have increased lymphocyte infiltration and decreased local inflammatory cytokine production after CLP.</bold>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
TLR9-/- mice have increased lymphocyte infiltration and decreased local inflammatory cytokine production after CLP. 12 h after CLP or sham laparotomy, the numbers of viable splenocytes (A) and infiltrating peritoneal lymphocytes (B) were counted on a hemocytometer (BrightLine; Hausser Scientific) after Trypan blue staining (three to five mice per group). Peritoneal cells are expressed per milliliter of peritoneal fluid. (C) Peritoneal cells pooled from three to five mice 12 h after CLP were cultured without restimulation for 24 h, and the supernatant cytokine levels were determined with a cytometric bead array. Peritoneal cells from mice that underwent sham laparotomy secreted a minimal amount of cytokines (not depicted). Data shown are means of values +/- SEM obtained from individual mice (except for cells pooled in C) and are representative of at least two independent experiments. *, P < 0.05.
###end p 10
###begin title 11
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
TLR9-/- DCs are protective during sepsis
###end title 11
###begin p 12
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 691 702 691 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 367 373 <span type="species:ncbi:9606">humans</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
A variety of cells express TLR9, most notably those of myeloid lineage. In mice, TLR9 is primarily expressed on DCs, B cells, and, to a lesser extent, macrophages (11, 12). DCs play a pivotal role in sepsis, and DC recruitment to sites of inflammation in response to chemotactic stimuli is necessary for an optimal immune response (13, 14). During sepsis in mice and humans, the number of DCs is reduced (2, 15). In addition, depletion of the remaining DCs in an inducible model of DC ablation demonstrated that DCs are protective during sepsis (16). Furthermore, intrapulmonary transfer of DCs to mice 2 wk after sublethal CLP has been shown to reverse the sepsis-induced susceptibility to Aspergillus infection (17).
###end p 12
###begin p 13
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 611 614 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 661 664 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 796 797 796 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 805 806 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 824 825 820 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 833 834 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 862 863 854 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 945 948 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
We therefore determined whether DCs were altered in TLR9-/- mice during sepsis. As expected, DCs were reduced in the spleen and peritoneum of WT mice after CLP. However, the reverse was seen in TLR9-/- mice, as sepsis actually increased the number of DCs in both the spleen and peritoneum (Fig. 3 A). We then examined the maturation, function, and subset composition of DCs 12 h after CLP. There was no difference in DC maturation between WT and TLR9-/- mice after sham laparotomy, as measured by CD40, CD80, and CD86 expression. However, CLP induced a similar increase in the maturation of DCs from WT and TLR9-/- mice (Fig. S1 A, available at ). DCs from TLR9-/- mice that underwent CLP induced greater alloproliferation (Fig. S1 B). There was no difference in the composition of myeloid (CD11b+CD8alpha-), lymphoid (CD11b-CD8alpha+), and plasmacytoid (mPDCA-1+) DCs from the spleen (Fig. S1 C) or peritoneum (not depicted) between WT and TLR9-/- mice after CLP.
###end p 13
###begin p 14
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR9<sup>&#8722;/&#8722;</sup> DCs reduce the sepsis-induced lethality of WT mice.</bold>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 484 485 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 526 527 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 705 706 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 870 873 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
TLR9-/- DCs reduce the sepsis-induced lethality of WT mice. (A) 12 h after CLP or sham laparotomy, the number of conventional DCs (CD11chighMHCII+) were determined by flow cytometry in the spleen and peritoneal fluid of WT or TLR9-/- mice (three to five mice per group). (B) The survival rates of WT mice receiving WT or TLR9-/- DCs were monitored for 6 d after CLP (23 mice per group, with data pooled from two experiments, each of which had similar statistical significance). (C) 107 Flt3L-expanded WT or TLR9-/- DCs (CD45.2+) were injected i.v. into CD45.1 WT recipients (three to five mice per group). 12 h after transfer, the mice underwent CLP or sham laparotomy, and 12 h later the number of CD45.2+ DCs were enumerated from the peritoneal cells by flow cytometry. (D) Dilutions of blood or peritoneal lavage fluid obtained from WT mice pretreated with WT or TLR9-/- DCs 12 h after CLP were cultured on BHI agar plates, and the number of bacterial colonies was counted (five mice per group). (E) Serum cytokine levels were determined 12 h after CLP by cytometric bead array (five mice per group). Data shown are means of values +/- SEM obtained from individual mice and are representative of at least two independent experiments. *, P < 0.05.
###end p 14
###begin p 15
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 351 359 351 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 415 418 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 575 583 575 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
To ascertain whether TLR9-/- DCs were protective, we transferred them into WT mice before CLP. Although adoptive transfer of WT DCs did not affect survival, the transfer of TLR9-/- DCs significantly decreased mortality (Fig. 3 B). This coincided with greater accumulation of transferred TLR9-/- DCs than WT DCs in the peritoneum of WT mice after CLP (Fig. 3 C). The reduced mortality after adoptive transfer of TLR9-/- DCs was also associated with a decrease in the burden of blood and peritoneal bacteria (Fig. 3 D), as well as lower serum levels of inflammatory cytokines (Fig. 3 E). Thus, the adoptive transfer of TLR9-/- DCs was sufficient to reduce the extent of bacterial infection and the associated inflammatory response in WT mice.
###end p 15
###begin title 16
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
TLR9-/- mice have a greater influx of granulocytes into the peritoneum
###end title 16
###begin p 17
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 323 326 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 367 375 367 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 504 507 504 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 641 644 641 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
Early clearance of bacteria is mediated by granulocytes and is critical for the prevention of an overwhelming immune response (18). Because TLR9-/- mice had enhanced bacterial clearance, we assessed their peritoneal granulocyte content. CLP was associated with a robust recruitment of granulocytes to the peritoneum in TLR9-/- mice and to a lesser extent in WT mice (Fig. 4 A). To determine if granulocytes were required for the enhanced survival observed in TLR9-/- mice, we performed CLP in WT and TLR9-/- animals after antibody-mediated depletion of granulocytes. Indeed, depletion of granulocytes abrogated the survival advantage of TLR9-/- mice (Fig. 4 B).
###end p 17
###begin p 18
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Peritoneal granulocytes are increased by CLP and are necessary for protection.</bold>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 523 524 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 587 590 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 742 743 741 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 889 890 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 978 979 977 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1005 1008 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
Peritoneal granulocytes are increased by CLP and are necessary for protection. (A) 12 h after CLP or sham laparotomy, the number of peritoneal granulocytes in WT or TLR9-/- mice (three to five mice per group) was determined by flow cytometry. (B) WT or TLR9-/- mice received 500 mug anti-GR1 antibody or isotype control 24 and 2 h before CLP, and the survival rates were monitored for 6 d after CLP (15 mice per group, with data pooled from three experiments, each of which had similar statistical significance). (C) 2 x 106 CD45.1 splenic granulocytes were injected i.v. into WT or TLR9-/- (CD45.2) recipients (three to five mice per group). 12 h after transfer, the mice underwent CLP or sham laparotomy, and 12 h later the number of CD45.1+ granulocytes were enumerated from the peritoneal cells by flow cytometry. (D) 12 h after CLP or sham laparotomy, the number of granulocytes (Ly6G+) was determined by flow cytometry in the peritoneal fluid of WT mice pretreated with 107 Flt3L-expanded WT or TLR9-/- DCs (three to five mice per group). Treatment with anti-GR1 antibody achieved >97% depletion of granulocytes at the time of and 24 h after CLP (not depicted). Data shown are means of values +/- SEM obtained from individual mice and are representative of at least two independent experiments. *, P < 0.05.
###end p 18
###begin p 19
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 178 186 178 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 264 272 264 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 362 365 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 618 621 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 654 662 654 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 809 812 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 873 876 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 948 951 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1068 1076 1068 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 934 938 <span type="species:ncbi:10090">mice</span>
Activated DCs have been shown to promote granulocyte chemotaxis in vivo by the secretion of chemokines (19). TLR9-/- mice demonstrated accumulation of peritoneal DCs during CLP (Fig. 3 A), and transfer of TLR9-/- DCs was sufficient to protect WT animals from CLP (Fig. 3 B). We therefore sought to determine if preferential granulocyte recruitment occurs in TLR9-/- animals and if DCs from TLR9-/- mice increased granulocyte trafficking to the peritoneum. After adoptive transfer of congenic WT granulocytes into WT and TLR9-/- mice before CLP, a greater number of WT granulocytes accumulated in the peritoneum of TLR9-/- versus WT recipients after CLP (Fig. 4 C). Furthermore, there was no significant difference in the number of adoptively transferred granulocytes in the blood or spleen between WT and TLR9-/- mice after CLP (unpublished data). Adoptive transfer of TLR9-/- DCs enhanced granulocyte recruitment, as treatment of WT mice with TLR9-/- DCs before CLP led to a significantly increased number of peritoneal granulocytes than adoptive transfer of WT DCs (Fig. 4 D).
###end p 19
###begin title 20
Inhibitory CpG (iCpG) reduces the mortality of polymicrobial sepsis
###end title 20
###begin p 21
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 167 169 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 255 263 254 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 684 689 <span type="species:ncbi:10090">mouse</span>
Because TLR9-/- mice survived septic peritonitis, we postulated that TLR9 blockade in WT mice may protect them from sepsis. A single 100-mug dose of an iCpG sequence (20) administered immediately before CLP significantly improved the survival of WT mice (Fig. 5 A). It is possible that multiple or higher iCpG doses would achieve even greater survival in WT mice subjected to CLP. Using lower doses, we found that 50 mug achieved 30% survival in 10 mice (P = 0.1), whereas a 5-mug dose did not yield any survivors (unpublished data). In vitro, iCpG also inhibited the production of inflammatory cytokines when WT splenocytes were cultured directly with heat-inactivated contents from mouse cecum (Fig. S2, available at ).
###end p 21
###begin p 22
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TLR9 inhibition protects WT mice from CLP.</bold>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
TLR9 inhibition protects WT mice from CLP. (A) Immediately before CLP, WT mice received 100 mug iCpG or control oligodeoxynucleotide (ODN), and survival rates were monitored for 6 d. (B) 12 and 18 h after CLP, WT mice received 100 mug iCpG or control ODN, and survival rates were monitored for 6 d. Survival curves of mice treated with iCpG at 3 and 6 h were similar to the one shown for the 12-h iCpG group (not depicted). Data shown include 15 mice per group, pooled from three experiments, each of which had similar statistical significance.
###end p 22
###begin p 23
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 437 443 437 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 61 67 <span type="species:ncbi:9606">humans</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
Because there is often a delay in the diagnosis of sepsis in humans, we determined the window of time during which iCpG could offer protection. Dramatically, we found that iCpG protected against mortality up to 12 h after CLP (Fig. 5 B). Thus, continued TLR9 stimulation was necessary for progression to death, because WT mice could be rescued at 12 h despite already being burdened by high bacterial counts and widespread inflammation (Fig. 1).
###end p 23
###begin p 24
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 173 190 173 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii</italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1001 1002 1001 1002 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1241 1242 1241 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1653 1656 1653 1656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1695 1698 1695 1698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1748 1749 1748 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 173 190 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
###xml 1699 1703 <span type="species:ncbi:10090">mice</span>
TLR9-/- mice have been shown to be highly susceptible to Gram-negative bacterial pneumonia (21), Gram-positive pneumonia (22), and infection with the intracellular parasite Toxoplasma gondii (23). In contrast, we have found TLR9-/- mice to be markedly resistant to septic peritonitis. One potential explanation for this apparent discrepancy may be the diversity and magnitude of TLR stimulation between infection with a single pathogen and polymicrobial peritonitis. TLR stimulation may be protective up to a certain threshold, beyond which it becomes detrimental. It is conceivable that during infection by a single pathogen there is a restricted degree of TLR stimulation that initiates protective innate immunity, whereas in polymicrobial peritonitis there is widespread TLR stimulation that leads to an exaggerated inflammatory response. Nevertheless, in certain settings, stimulation of individual TLRs can be lethal. For instance, administration of bacterial DNA or LPS after sensitization with d-galactosamine is rapidly lethal (24, 25). In CLP, a more relevant model of clinical sepsis (26), the diverse pathogens residing in the enteric tract stimulate multiple TLRs, but inhibition of TLR9, as we have shown, and not TLR2 or TLR4 (7), affects the outcome. In polymicrobial infection, it has generally been assumed that the stimulation of multiple TLRs collectively promotes the pathological hyperinflammatory response. Our findings, however, suggest a hierarchy of TLR responses, with TLR9 having a major role in the immunopathogenesis of polymicrobial sepsis. This is exemplified by the near abrogation of serum inflammatory cytokines in TLR9-/- mice, a finding also observed in MyD88-/- mice, which are largely devoid of TLR signaling (7).
###end p 24
###begin p 25
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 492 500 492 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
Collectively, our data demonstrate that the absence of TLR9 signaling during peritoneal sepsis promotes the local influx of DCs, which is associated with an enhanced granulocyte response that is necessary for survival. The dependence on granulocytes may be independent of TLR9 or DC involvement. Nevertheless, we speculate that DCs mediate the enhanced granulocyte recruitment into the peritoneum, because adoptive transfer of TLR9-/- DCs into WT recipients enhanced granulocyte recruitment (Fig. 4 D). DCs are known to produce high levels of chemokines, and their ability to do so has been shown to enhance the recruitment and activation of granulocytes (19). Finally, the availability of inhibitors to human TLR9 provides the opportunity to translate our findings to the treatment of human sepsis.
###end p 25
###begin title 26
MATERIALS AND METHODS
###end title 26
###begin title 27
Animal procedures.
###end title 27
###begin p 28
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 981 983 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">Mice</span>
###xml 618 622 <span type="species:ncbi:10090">Mice</span>
6-10-wk-old WT CD45.1 and CD45.2 C57BL/6 (B6) mice were purchased from the Jackson Laboratory. TLR9-/- mice on a B6 background (obtained from S. Akira, Osaka University, Osaka, Japan) were bred in our laboratory. For CLP, the surgeon was blinded to the experimental groups, and a midline laparotomy incision was performed in an aseptic fashion and the cecum was ligated distal to the ileocecal valve, taking care not to disrupt bowel continuity. The ligated cecum was punctured once with an 18-gauge needle, as previously described (27). Mice subjected to sham laparotomy underwent the same procedure without the CLP. Mice were monitored every 8 h for 6 d to determine survival. Granulocyte depletion was accomplished with an i.p. injection of 500 mug anti-GR1 antibody (RB6.8C5; Monoclonal Core Facility, Sloan-Kettering Institute) 24 and 2 h before CLP. In vivo blockade of TLR9 was accomplished with a subcutaneous injection of 100 mug iCpG or control DNA sequence (InvivoGen) (28). The animals were maintained in a pathogen-free animal housing facility at the Memorial Sloan-Kettering Cancer Center. All procedures were approved by the Institutional Animal Care and Use Committee.
###end p 28
###begin title 29
Cell isolation and adoptive transfer.
###end title 29
###begin p 30
###xml 799 800 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 820 823 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 852 853 851 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 954 957 953 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
Peritoneal cells were isolated by injecting 5 ml PBS i.p. and retrieving the fluid 1 min later. The data depicted in the figures indicate the cell or bacterial count per milliliter of the retrieved peritoneal fluid. Spleens were mechanically disrupted, digested in 0.05% type IV collagenase (Sigma-Aldrich), and rendered free of erythrocytes by treatment with a hypotonic solution of ammonium chloride. In vivo expansion of DCs was accomplished with daily i.p. injections of 10 mug of recombinant human fms-like tyrosine kinase 3 ligand (Flt3L; Amgen) for 10 d. Expanded splenic DCs were purified with anti-CD11c immunomagnetic beads (Miltenyi Biotec). Splenic granulocytes were purified from CD45.1 mice with an anti-Ly6G (1A8) biotinylated antibody and streptavidin microbeads (Milteny Biotec). 107 expanded WT or TLR9-/- CD45.2 splenic DCs or 2 x 106 splenic CD45.1 granulocytes were injected into the lateral tail vein of CD45.1 or CD45.2 WT and TLR9-/- mice, respectively. Adoptively transferred cells were also labeled with 50 muM CFSE (Invitrogen) to facilitate their proper identification.
###end p 30
###begin title 31
Flow cytometry.
###end title 31
###begin p 32
###xml 194 195 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 241 245 236 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 250 251 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 289 290 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Flow cytometry was performed on a FACSAria (BD Biosciences). Fc receptors were blocked with 1 mug anti-FcgammaRIII/II antibody (2.4G2; Monoclonal Core Facility, Sloan-Kettering Institute) per 106 cells. Conventional DCs were defined as CD11chighMHCII+ and granulocytes were defined as Ly6G+ (Fig. S3, available at ). Cells were stained with fluorescent-conjugated CD11c (HL-3), MHCII (AF6-120.1, I-Ab), CD45.1 (A20), CD45.2 (104), and Ly6G (1A8) antibodies (BD Biosciences). Dead cells were excluded with 7-amino-actinomycin D (BD Biosciences).
###end p 32
###begin title 33
Measurement of cytokines and CFUs.
###end title 33
###begin p 34
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
For cytokine measurement, peritoneal cells were cultured at a concentration of 106 cells/ml in media for 24 h. Blood was obtained by direct cardiac puncture. Supernatant and serum cytokine levels were determined using a cytometric bead array (BD Biosciences). Aerobic bacterial CFUs were determined by plating serial dilutions of blood and peritoneal fluid on brain-heart infusion (BHI) agar plates.
###end p 34
###begin title 35
Statistics.
###end title 35
###begin p 36
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical significance was determined by the Student's t test and the log-rank test using statistical software (Prism 4.0; GraphPad Software, Inc.). P < 0.05 was deemed significant.
###end p 36
###begin title 37
Online supplemental material.
###end title 37
###begin p 38
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows DC maturation, function, and subset composition in WT and TLR9-/- mice after CLP. Fig. S2 shows that iCpG blocks cytokine secretion by WT splenocytes cultured with cecal contents in vitro. Fig. S3 shows representative gating for flow cytometry used in these experiments. Supplemental materials and methods provides information about antibodies used and the mixed leukocyte reaction performed. Online supplemental material is available at .
###end p 38
###begin p 39
The authors would like to acknowledge Dr. Eric Pamer for helpful discussions and advice.
###end p 39
###begin p 40
This work was supported by National Institutes of Health grants AI70658 and DK068346.
###end p 40
###begin p 41
The authors have no conflicting financial interests.
###end p 41

